menopause

Experts explain the role and safety of Bayer's elinzanetant to treat vasomotor symptoms since its approval in October 2025.

* For women, clinical discussions are currently underway with the FDA to bring regulatory approval for female-specific testosterone gels and oral formats to the US market within the next two to three years. There is an undeniable buzz around testosterone for women right now. While many...

Women’s sex lives are being quietly destroyed, and their doctors don’t even know it… Sexual medicine specialist Dr Rachel Rubin reveals the hidden hormone crisis, how prescription drugs can impact sex, and the treatments most doctors aren't prescribing like Hormone Replacement Therapy. Dr...

In this episode of Pearls & Perspectives, host Amy Pearlman, MD, is joined by Larry Lipshultz, MD, and Rachel Rubin, MD, on the sidelines of the 2026 American Urological Association (AUA) Annual Meeting in Washington, DC, for a wide-ranging conversation on advocacy, sexual medicine, and the...

Start low and go slow, where have we heard that one before LOL! https://www.contemporaryobgyn.net/view/individualized-trt-demonstrates-broad-symptom-improvements-beyond-sexual-function Testosterone replacement therapy (TRT) in women may offer multidimensional symptom improvement...

In this episode, Dr. Rena Malik welcomes Dr. Rachel Rubin to explore the often-overlooked aspects of women's sexual health, including clitoral anatomy, clitoral adhesions, and the impact of hormones throughout the lifespan. The conversation covers essential topics such as sexual pain, the role...

In this interview, Dr. Amy Pearlman explains genitourinary syndrome of menopause in a clear and practical way. Genitourinary syndrome of menopause is a chronic condition driven by estrogen deficiency after menopause and can present with vaginal dryness, burning, irritation, pain with sex...

Why are so many women still being told estrogen is dangerous? In this episode, Dr Louise Newson is joined by oncologist and author of Estrogen Matters, Dr Avrum Bluming, to explore how fear around hormones took hold and why it persisted for so long. They also revisit the evidence behind the...

Abstract INTRODUCTION AND OBJECTIVES: Testosterone replacement therapy (TRT) is an established treatment for hyposexual desire in postmenopausal women, yet the broader effects of TRT on menopausal symptoms remain uncertain. Our research aims to define optimal testosterone levels for symptomatic...

Take Home Message

In this episode of unPAUSED, Dr. Mary Claire Haver sits down with Dr. Kelly Casperson, a urologist, author, and host of the podcast “You Are Not Broken”. Dr. Casperson trained in a specialty that treats both men and women, which gave her an early and clear view of the gender gap in sexual...

A major shift just happened in menopause care. With the FDA removing outdated boxed warnings on hormone therapy—first announced in November 2025 and finalized in February 2026—we’re entering a new era. But what’s actually changed, and what does it mean for patients and clinicians? Join Dr...

This episode is a MUST listen. Mel calls it one of the most important conversations she has ever had on The Mel Robbins Podcast. Most women don’t know this, and this information could save the life of a woman you love. If you are thinking you’re “fine,” while quietly suffering through...

Sexual medicine is underfunded, misunderstood, and often dismissed. But it's also one of the most collaborative fields in healthcare. Dr. Tami Rowen and I recap this year's ISSWSH conference and what it revealed about where the field is heading. Dr. Tami Rowen is an associate professor of OBGYN...

https://www.auanet.org/about-us/media-center/press-center/aua-hhs-fda-cdc-to-launch-landmark-womens-health-partnership BALTIMORE, March 12, 2026 (GLOBAL NEWSWIRE) — The American Urological Association (AUA), together with the Urology Care Foundation (UCF), is proud to announce a new formal...

In this episode, Dr Louise Newson is joined by urologist, educator and hormone health advocate Dr Kelly Casperson to challenge some of the most persistent myths surrounding testosterone and women’s health. Drawing on both clinical experience and scientific evidence, they explore why testosterone...

In this episode of the You Are Not Broken Podcast, Dr. Kelly Casperson shares the biggest takeaways from the 2026 ISSWSH Conference (International Society for the Study of Women’s Sexual Health). We cover the latest research on women’s sexual health, hormones, testosterone therapy, and new...

Struggling to understand female sexual dysfunction (FSD) and its impact on women’s health? In this episode, we sit down with Dr. Hackett to explore the causes, treatments, and myths around this often-overlooked condition. TOPICS DISCUSSED: * What is female sexual dysfunction, and how common...

* “d3-T is a novel, structurally identical form of testosterone where select hydrogen molecules have been substituted with deuterium. This small change creates a significant breakthrough.” * AVA-291 is a “next-generation testosterone designed to retain [testosterone]’s androgen activity while...

In this episode, Dr Louise Newson is joined by urologist and sexual medicine specialist Prof Mohit Khera to talk about testosterone in women and why it remains one of the most misunderstood and underused hormones in medicine. Crucially, this conversation goes far beyond libido. This is a...

Vaginal rejuvenation is often misunderstood, misrepresented, and overdue for honest conversations in medicine. In this crossover episode between BackTable Urology and BackTable OBGYN, Dr. Nirit Rosenblum, a urology and OBGYN professor at NYU Langone Medical Center, is joined by Dr. Karyn Eilber...

Think testosterone is just a male hormone? Think again. In this game-changing conversation, Shalin Shah, CEO of Marius Pharmaceuticals, debunks a major myth in women’s health. Spoiler alert: women have more testosterone than estrogen, and when those levels drop during perimenopause and...

"Cardiometabolic Health: Do Sex Steroids Matter?" which looks at the role sex steroids play in cardiovascular health across the lifespan. Susan R. Davis My team who have contributed to the work presented Conclusions

https://kellycaspersonmd.substack.com/p/2026-goals KELLY CASPERSON, MD DEC 29, 2025 The past decade (or 2025 for that matter) has shown that progress in women’s health does not result from being polite, patient, or quiet. It advances when individuals speak uncomfortable truths openly and...

The FDA just held a hearing on menopause—and experts say it’s time to rethink hormone labels. Dr. James Simon joins Fempower Health to explain what needs to change and what it means for women. Chapters: 00:00 Intro – Why This Conversation Matters 00:14 Why Estrogen Labels Matter 00:20...

* Key discussions include the safety and efficacy of low-dose local vaginal estrogen, the importance of a patient-centered, shared decision-making approach, and clear consensus on when to use various therapies. The new interdisciplinary guidelines for the Genitourinary Syndrome of...

2025 American Heart Association Scientific Sessions Dr. Susan Davis * in the process of doing safety parameters, we found that when we gave women testosterone, we caused blood vessel dilation just like we saw when we gave women estrogen and in fact, when we gave women an ACUTE dose of...

CUA WEBINAR 2025 Summary

FDA Commissioner and subject matter experts from the Center for Drug Evaluation and Research discuss the agency's recent announcement regarding removal of the “black box warning” for hormone replacement therapy. Proposed Changes Related to Safety Information Labeling Proposed...

Dr. Davis cutting deep here! 27:30 HRT loses its black box warning 29:29 The harm of over prescribing and big dose HRT There is a lot we don’t know about the menopause. It’s a stage of life that can be difficult to navigate for many women - especially since the advice online is all over...

* These effects can be life-altering and can lead to social withdrawal, relationship strain and reduced capacity to work. With key neurotransmitter systems including serotonin, allopregnanolone and gamma-aminobutyric acid (GABA) being modulated by fluctuating levels of oestradiol, progesterone...